| 000 | 01556 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514000246.0 | ||
| 264 | 0 | _c20010621 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0361-8609 | ||
| 024 | 7 |
_a10.1002/ajh.1089 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarone, S | |
| 245 | 0 | 0 |
_aHigh-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cJun 2001 |
||
| 300 |
_a119-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBlast Crisis _xdrug therapy |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aCytogenetic Analysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBaer, M R | |
| 700 | 1 | _aSait, S N | |
| 700 | 1 | _aLawrence, D | |
| 700 | 1 | _aBlock, A W | |
| 700 | 1 | _aWetzler, M | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 67 _gno. 2 _gp. 119-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.1089 _zAvailable from publisher's website |
| 999 |
_c11276165 _d11276165 |
||